Top Story

FDA approves Prezcobix for treatment of HIV-1

January 30, 2015

The FDA has approved an antiretroviral combination drug for the treatment of HIV-1 infection in adults, according to a press release.

Darunavir/cobicistat (Prezcobix, Janssen Therapeutics), an HIV-1 protease inhibitor combined with a CYP3A4 inhibitor, is intended for treatment-naive and treatment-experienced adults without darunavir resistance-associated substitutions. It is a once-daily, fixed-dose tablet, containing 800 mg darunavir and 150 mg cobicistat, and is intended to be taken orally with other antiretrovirals and food.

The Liver Meeting 2014: The Take Home Meeting News Coverage

The Liver Meeting 2014: The Take Home

January 30, 2015
Every year at The Liver Meeting, an international group of experts convene to discuss the latest in hepatology. HCV Next had the opportunity to sit down with leading…
Meeting News Coverage

Blood transfusions during CABG increased risk for pneumonia

January 30, 2015
Patients had a greater risk for developing postoperative pneumonia if they received red blood cell transfusions during or after isolated CABG surgery, according to data…
In the Journals

CDC: 956 MERS cases confirmed since September 2012

January 30, 2015
As of Jan. 23, there have been 956 laboratory-confirmed cases of Middle East respiratory syndrome, or MERS, coronavirus, including 351 deaths since it was first…
In the Journals

Daclatasvir with PEG-IFN a-2a/ribavirin reduced treatment time for HCV

January 30, 2015
In a phase 2b clinical trial, a regimen of daclatasvir combined with pegylated interferon alfa-2a and ribavirin was safe and generally well tolerated among patients with…
More News Headlines »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
Meeting News Coverage Video
thumbnail for video 3911388507001

Student education, immunization requirements necessary to prevent outbreaks on college campuses

November 28, 2014
NEW YORK — James C. Turner, MD, executive director of the department of student health and the National Social…
More »
CME
HBV

Critical Issues in HBV
HBV Management in Complex Populations: Volume 1, Number 2

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
morganatic-roan